Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu
Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu Detail:
Manufacturer with High Purity and Stable Quality
Commercial Supply Sofosbuvir (CAS: 1190307-88-0) and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
Name | triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane |
Synonyms | 2-(triphenyl-phosphanylidene)-propionic acid ethyl ester |
CAS Number | 21382-82-1 |
CAT Number | RF-PI179 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C23H23O2P |
Molecular Weight | 362.41 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Yellow Powder |
Purity / Analysis Method | ≥98.0% (HPLC) |
Loss on Drying | ≤1.0% (60℃, 2h) |
Sum of PH3P+PH3PO | ≤2.0% (HPLC) |
Unspecified Related Substance | ≤0.5% (HPLC) |
Test Standard | Enterprise Standard |
Usage | Intermediate of Sofosbuvir (CAS: 1190307-88-0) |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Manufacturer with High Purity and Stable Quality
Commercial Supply Sofosbuvir (CAS: 1190307-88-0) and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
Sofosbuvir is a drug used for the treatment of hepatitis C. It is recommended to be used in combination with other drugs (such as velpatasvir) for the first-line treatment for HCV genotypes 1, 2, 3, 4, 5, and 6. It takes effect through acting as a nucleotide analog inhibitor, being capable of specially inhibiting the HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase. Oral sofosbuvir was generally well tolerated in patients with chronic hepatitis C. The most commonly reported adverse events and laboratory abnormalities in patients receiving sofosbuvir plus ribavirin with or without peginterferon-alpha were consistent with those expected in patients receiving treatment with ribavirin and peginterferon-alpha, and co-administering sofosbuvir did not appear to increase the frequency or severity of these adverse events or laboratory abnormalities.
Product detail pictures:
Related Product Guide:
It is a good way to improve our products and service. Our mission is to develop creative products to customers with a good experience for Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu , The product will supply to all over the world, such as: Canberra, Cancun, Argentina, We aspire to meet the demands of our customers globally. Our range of products and services is continuously expanding to meet customers' requirements. We welcome new and old customers from all walks of life to contact us for future business relationships and achieving mutual success!
By Irma from Madagascar - 2017.11.12 12:31
It is a very good, very rare business partners, looking forward to the next more perfect cooperation!
By mary rash from Swiss - 2017.06.16 18:23